Forebrain dopaminergic-cholinergic interactions, attentional effort, psychostimulant addiction and schizophrenia

  • Martin Sarter
  • John P. Bruno
  • Vinay Parikh
  • Vicente Martinez
  • Rouba Kozak
  • Jerry B. Richards
Part of the Experientia Supplementum book series (EXS, volume 98)


Nucleus Accumbens Cholinergic Neuron Basal Forebrain Choline Transporter Cholinergic Input 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Semba K (2000) Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behav Brain Res 115: 117–141PubMedGoogle Scholar
  2. 2.
    Woolf NJ (1991) Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37: 475–524PubMedGoogle Scholar
  3. 3.
    Zaborszky L, Pang K, Somogyi J, Nadasdy Z, Kallo I (1999) The basal forebrain corticopetal system revisited. Ann N Y Acad Sci 877: 339–367PubMedGoogle Scholar
  4. 4.
    Sarter M, Bruno JP (2002) The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections. Eur J Neurosci 15: 1867–1873PubMedGoogle Scholar
  5. 5.
    McGaughy J, Everitt BJ, Robbins TW, Sarter M (2000) The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 115: 251–263PubMedGoogle Scholar
  6. 6.
    Sarter M, Givens B, Bruno JP (2001) The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res Rev 35: 146–160PubMedGoogle Scholar
  7. 7.
    Sarter M, Bruno JP (2000) Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95: 933–952PubMedGoogle Scholar
  8. 8.
    Sarter M, Bruno JP (1997) Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23: 28–46PubMedGoogle Scholar
  9. 9.
    Sarter M, Bruno JP, Turchi J (1999) Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders. Ann N Y Acad Sci 877: 368–382PubMedGoogle Scholar
  10. 10.
    Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Ann Rev Psychol 48: 649–684Google Scholar
  11. 11.
    Mesulam MM (1990) Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 28: 597–613PubMedGoogle Scholar
  12. 12.
    Chiba AA, Bucci DJ, Holland PC, Gallagher M (1995) Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J Neurosci 15: 7315–7322PubMedGoogle Scholar
  13. 13.
    Dalley JW, McGaughy J, O’Connell MT, Cardinal RN, Levita L, Robbins TW (2001) Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 21: 4908–4914PubMedGoogle Scholar
  14. 14.
    Voytko ML (1996) Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention? Behav Brain Res 75: 13–25PubMedGoogle Scholar
  15. 15.
    McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002) Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22: 1905–1913PubMedGoogle Scholar
  16. 16.
    McGaughy J, Kaiser T, Sarter M (1996) Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110: 247–265PubMedGoogle Scholar
  17. 17.
    Sarter M, Bruno JP, Givens B (2003) Attentional functions of cortical cholinergic inputs: what does it mean for memory? Neurobiol Learn Mem 80: 245–256PubMedGoogle Scholar
  18. 18.
    Baxter MG, Murg SL (2002) The basal forebrain cholinergic system and memory. Beware of dogma. In: LR Squire, DL Schachter (eds): Neuropsychology of memory. The Guilford Press, New York, 425–436Google Scholar
  19. 19.
    Butt AE, Bowman TD (2002) Transverse patterning reveals a dissociation of simple and configural association learning abilities in rats with 192 IgG-saporin lesions of the nucleus basalis magnocellularis. Neurobiol Learn Mem 77: 211–233PubMedGoogle Scholar
  20. 20.
    Berger-Sweeney J, Stearns NA, Frick KM, Beard B, Baxter MG (2000) Cholinergic basal forebrain is critical for social transmission of food preferences. Hippocampus 10: 729–738PubMedGoogle Scholar
  21. 21.
    Weinberger NM (2003) The nucleus basalis and memory codes: auditory cortical plasticity and the induction of specific, associative behavioral memory. Neurobiol Learn Mem 80: 268–284PubMedGoogle Scholar
  22. 22.
    Edeline JM (2003) The thalamo-cortical auditory receptive fields: regulation by the states of vigilance, learning and the neuromodulatory systems. Exp Brain Res 153: 554–572PubMedGoogle Scholar
  23. 23.
    Sarter M, Hasselmo ME, Bruno JP, Givens B (2005) Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and top-down cholinergic modulation of signal detection. Brain Res Rev 48: 98–111PubMedGoogle Scholar
  24. 24.
    Nelson CL, Sarter M, Bruno JP (2005) Prefrontal cortical modulation of acetylcholine release in the posterior parietal cortex. Neuroscience 132:347–359.PubMedGoogle Scholar
  25. 25.
    Zaborszky L, Gaykema RP, Swanson DJ, Cullinan WE (1997) Cortical input to the basal forebrain. Neuroscience 79: 1051–1078PubMedGoogle Scholar
  26. 26.
    Dalley JW, Theobald DE, Bouger P, Chudasama Y, Cardinal RN, Robbins TW (2004) Cortical cholinergic function and deficits in visual attentional performance in rats Following 192 IgG-Saporin-induced lesions of the medial prefrontal cortex. Cereb Cortex 14: 922–932PubMedGoogle Scholar
  27. 27.
    Gill TM, Sarter M, Givens B (2000) Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J Neurosci 20: 4745–4757PubMedGoogle Scholar
  28. 28.
    Posner MI, Petersen SE (1990) The attention system of the human brain. Ann Rev Neurosci 13: 25–42PubMedGoogle Scholar
  29. 29.
    Kozak R, Bruno JP, Sarter M (2006) Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex 16: 9–17PubMedGoogle Scholar
  30. 30.
    Turchi J, Sarter M (2001) Bidirectional modulation of basal forebrain N-methyl-Daspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience 104: 407–417PubMedGoogle Scholar
  31. 31.
    Arnold HM, Burk JA, Hodgson EM, Sarter M, Bruno JP (2002) Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience 114: 451–460PubMedGoogle Scholar
  32. 32.
    Giovannini MG, Giovannelli L, Bianchi L, Kalfin R, Pepeu G (1997) Glutamatergic modulation of cortical acetylcholine release in the rat: a combined in vivo microdialysis, retrograde tracing and immunohistochemical study. Eur J Neurosci 9: 1678–1689PubMedGoogle Scholar
  33. 33.
    Rasmusson DD, Szerb IC, Jordan JL (1996) Differential effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor antagonists applied to the basal forebrain on cortical acetylcholine release and electroencephalogram desynchronization. Neuroscience 72: 419–427PubMedGoogle Scholar
  34. 34.
    Fadel J, Sarter M, Bruno JP (2001) Basal forebrain glutamatergic modulation of cortical acetylcholine release. Synapse 39: 201–212PubMedGoogle Scholar
  35. 35.
    Berridge KC, Robinson TE (2003) Parsing reward. Trends Neurosci 26: 507–513PubMedGoogle Scholar
  36. 36.
    Zaborszky L (1992) Synaptic organization of basal forebrain cholinergic projection neurons. In: E Levin, MW Decker, LL Butcher (eds): Neurotransmitter Interactions and Cognitive Function. Birkhäuser, Boston, 27–65Google Scholar
  37. 37.
    Zaborszky L, Cullinan WE (1992) Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat. Brain Res 570: 92–101PubMedGoogle Scholar
  38. 38.
    Dudchenko P, Sarter M (1991) GABAergic control of basal forebrain cholinergic neurons and memory. Behav Brain Res 42: 33–41PubMedGoogle Scholar
  39. 39.
    Holley LA, Turchi J, Apple C, Sarter M (1995) Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacol 120: 99–108Google Scholar
  40. 40.
    Moore H, Sarter M, Bruno JP (1995) Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain. Neurosci Lett 189: 31–34PubMedGoogle Scholar
  41. 41.
    Moore H, Sarter M, Bruno JP (1993) Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 627: 267–274PubMedGoogle Scholar
  42. 42.
    Sarter M, Bruno JP, Dudchenko P (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacol 101: 1–17Google Scholar
  43. 43.
    Yang CR, Mogenson GJ (1989)Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res 489: 237–246PubMedGoogle Scholar
  44. 44.
    Nicola SM, Surmeier J, Malenka RC (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23: 185–215PubMedGoogle Scholar
  45. 45.
    O’Donnell P, Grace AA (1993) Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens. J Neurosci 13: 3456–3471PubMedGoogle Scholar
  46. 46.
    Floresco SB, Blaha CD, Yang CR, Phillips AG (2001) Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection. J Neurosci 21: 2851–2860PubMedGoogle Scholar
  47. 47.
    Floresco SB, Todd CL, Grace AA (2001) Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 21: 4915–4922PubMedGoogle Scholar
  48. 48.
    Meredith GE (1999) The synaptic framework for chemical signaling in nucleus accumbens. Ann N Y Acad Sci 877: 140–156PubMedGoogle Scholar
  49. 49.
    Mulder AB, Hodenpijl MG, Lopes da Silva FH (1998) Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci 18: 5095–5102PubMedGoogle Scholar
  50. 50.
    O’Donnell P (1999) Ensemble encoding in the nucleus accumbens. Psychobiology 27: 187–197Google Scholar
  51. 51.
    Brady AM, O’Donnell P (2004) Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 24: 1040–1049PubMedGoogle Scholar
  52. 52.
    Moore H, Fadel J, Sarter M, Bruno JP (1999) Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience 88: 811–822PubMedGoogle Scholar
  53. 53.
    Moore H, Stuckman S, Sarter M, Bruno JP (1995) Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling. Synapse 21: 324–331PubMedGoogle Scholar
  54. 54.
    Sarter M, Bruno JP, Berntson GG (2001) Psychotogenic properties of benzodiazepine receptor inverse agonists. Psychopharmacol 156: 1–13Google Scholar
  55. 55.
    Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93: 1325–1329PubMedGoogle Scholar
  56. 56.
    Bassareo V, Tanda G, Petromilli P, Giua C, Di Chiara G (1996) Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacol 124: 293–299Google Scholar
  57. 57.
    Bradberry CW, Lory JD, Roth RH (1991) The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J Neurochem 56: 748–752PubMedGoogle Scholar
  58. 58.
    Brose N, O’Neill RD, Boutelle MG, Anderson SM, Fillenz M (1987) Effects of an anxiogenic benzodiazepine receptor ligand on motor activity and dopamine release in nucleus accumbens and striatum in the rat. J Neurosci 7: 2917–2926PubMedGoogle Scholar
  59. 59.
    Tam SY, Roth RH (1985) Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142. Biochem Pharmacol 34: 1595–1598PubMedGoogle Scholar
  60. 60.
    McCullough LD, Salamone JD (1992) Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens. Psychopharmacol 109: 379–382Google Scholar
  61. 61.
    Ninan I, Kulkarni SK (1999) Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks. Brain Res 830: 337–344PubMedGoogle Scholar
  62. 62.
    Murphy BL, Arnsten AF, Jentsch JD, Roth RH (1996) Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci 16: 7768–7775PubMedGoogle Scholar
  63. 63.
    Murphy BL, Roth RH, Arnsten AF (1997) Clozapine reverses the spatial working memory deficits induced by FG7142 in monkeys. Neuropsychopharmacol 16: 433–437Google Scholar
  64. 64.
    Sarter M, Nelson CL, Bruno JP (2005) Cortical cholinergic transmission and cortical information processing following psychostimulant-sensitization: implications for models of schizophrenia. Schizophren Bull 31: 1–22Google Scholar
  65. 65.
    Neigh GN, Arnold HM, Rabenstein RL, Sarter M, Bruno JP (2004) Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release. Neuroscience 123: 635–645PubMedGoogle Scholar
  66. 66.
    Neigh GN, Arnold HM, Sarter M, Bruno JP (2001) Dissociations between the effects of intra-accumbens administration of amphetamine and exposure to a novel environment on accumbens dopamine and cortical acetylcholine release. Brain Res 894: 354–358PubMedGoogle Scholar
  67. 67.
    Zmarowski A, Sarter M, Bruno JP (2004) Modulation of cortical acetylcholine release via glutamatergic and D1 interactions in the nucleus accumbens. Society for Neuroscience Annual Meeting. Society for Neuroscience Abstracts, San Diego, CA, 950.914Google Scholar
  68. 68.
    Miner LA, Sarter M (1999) Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. Cogn Brain Res 7: 269–283Google Scholar
  69. 69.
    Himmelheber AM, Bruno JP, Sarter M (2000) Effects of intra-accumbens infusions of amphetamine or cis-flupenthixol on sustained attention performance in rats. Behav Brain Res 116: 123–133PubMedGoogle Scholar
  70. 70.
    Gaykema RP, Zaborszky L (1996) Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. Substantia nigra-ventral tegmental area projections to cholinergic neurons. J Comp Neurol 374: 555–577PubMedGoogle Scholar
  71. 71.
    Smiley JF, Subramanian M, Mesulam MM (1999) Monoaminergic-cholinergic interactions in the primate basal forebrain. Neuroscience 93: 817–829PubMedGoogle Scholar
  72. 72.
    Rodrigo J, Fernandez P, Bentura ML, de Velasco JM, Serrano J, Uttenthal O, Martinez-Murillo R (1998) Distribution of catecholaminergic afferent fibres in the rat globus pallidus and their relations with cholinergic neurons. J Chem Neuroanat 15: 1–20PubMedGoogle Scholar
  73. 73.
    Napier TC (1992) Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists. Synapse 10: 110–119PubMedGoogle Scholar
  74. 74.
    Momiyama T, Sim JA (1996) Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors. J Neurosci 16: 7505–7512PubMedGoogle Scholar
  75. 75.
    Momiyama T, Sim JA, Brown DA (1996) Dopamine D1-like receptor-mediated presynaptic inhibition of excitatory transmission onto rat magnocellular basal forebrain neurones. J Physiol 495 (Pt 1): 97–106PubMedGoogle Scholar
  76. 76.
    Johnson PI, Napier TC (1997) GABA-and glutamate-evoked responses in the rat ventral pallidum are modulated by dopamine. Eur J Neurosci 9: 1397–1406PubMedGoogle Scholar
  77. 77.
    Nelson CL, Sarter M, Bruno JP (2000) Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release. Psychopharmacol 151: 406–415Google Scholar
  78. 78.
    Day JC, Tham CS, Fibiger HC (1994) Dopamine depletion attenuates amphetamine-induced increases of cortical acetylcholine release. Eur J Pharmacol 263: 285–292PubMedGoogle Scholar
  79. 79.
    Arnold HM, Fadel J, Sarter M, Bruno JP (2001) Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain. Brain Res 894: 74–87PubMedGoogle Scholar
  80. 80.
    Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, Robbins TW (1994) 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 14: 2531–2544PubMedGoogle Scholar
  81. 81.
    Passetti F, Dalley JW, Robbins TW (2003) Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacol 165: 136–145Google Scholar
  82. 82.
    Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208–1215PubMedGoogle Scholar
  83. 83.
    Chudasama Y, Robbins TW (2004) Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacol 29: 1628–1636Google Scholar
  84. 84.
    Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528–8535PubMedGoogle Scholar
  85. 85.
    Goldman-Rakic PS, Muly III EC, Williams GV (2000) D(1) receptors in prefrontal cells and circuits. Brain Res Rev 31: 295–301PubMedGoogle Scholar
  86. 86.
    Ragozzino M (2000) The contribution of cholinergic and dopaminergic afferents in the rat prefrontal cortex to learning, memory, and attention. Psychobiology 28: 238–247.Google Scholar
  87. 87.
    Broersen LM, Heinsbroek RP, de Bruin JP, Olivier B (1996) Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol Psychiatry 40: 1083–1090PubMedGoogle Scholar
  88. 88.
    Broersen LM, Heinsbroek RP, de Bruin JP, Uylings HB, Olivier B (1995) The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 674: 221–229PubMedGoogle Scholar
  89. 89.
    Izaki Y, Hori K, Nomura M (1998) Dopamine and acetylcholine elevation on lever-press acquisition in rat prefrontal cortex. Neurosci Lett 258: 33–36PubMedGoogle Scholar
  90. 90.
    Laplante F, Srivastava LK, Quirion R (2004) Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neurochem 89: 314–323PubMedGoogle Scholar
  91. 91.
    Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nature Rev Neurosci 6: 48–56Google Scholar
  92. 92.
    Apparsundaram S, Martinez V, Parikh V, Kozak R, Sarter M (2005) Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J Neurosci 15: 3851–3856Google Scholar
  93. 93.
    Ferguson SM, Blakely RD (2004) The choline transporter resurfaces: new roles for synaptic vesicles? Mol Intervent 4: 22–37Google Scholar
  94. 94.
    Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD (2003) Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23: 9697–9709PubMedGoogle Scholar
  95. 95.
    Gates J, Jr., Ferguson SM, Blakely RD, Apparsundaram S (2004) Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J Pharmacol Exp Ther 310: 536–545PubMedGoogle Scholar
  96. 96.
    Guermonprez L, O’Regan S, Meunier FM, Morot-Gaudry-Talarmain Y (2002) The neuronal choline transporter CHT1 is regulated by immunosuppressor-sensitive pathways. J Neurochem 82: 874–884PubMedGoogle Scholar
  97. 97.
    Xie J, Guo Q (2004) Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane. J Biol Chem 279: 28266–28275PubMedGoogle Scholar
  98. 98.
    Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP (2004) Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci 20: 1545–1554PubMedGoogle Scholar
  99. 99.
    Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98: 1982–1987PubMedGoogle Scholar
  100. 100.
    Pecina S, Cagniard B, Berridge KC, Aldridge JW, Zhuang X (2003) Hyperdopaminergic mutant mice have higher “wanting” but not “liking” for sweet rewards. J Neurosci 23: 9395–9402PubMedGoogle Scholar
  101. 101.
    Berridge KC, Aldridge JW, Houchard KR, Zhuang X (2005) Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette’s. BMC Biol 3: 4PubMedGoogle Scholar
  102. 102.
    Westerink BH, de Boer P, Damsma G (1990) Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects. J Neurosci Methods 34: 117–124PubMedGoogle Scholar
  103. 103.
    Steiner H, Kitai ST (2000) Regulation of rat cortex function by D1 dopamine receptors in the striatum. J Neurosci 20: 5449–5460PubMedGoogle Scholar
  104. 104.
    Calabresi P, Centonze D, Gubellini P, Pisani A, Bernardi G (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23: 120–126PubMedGoogle Scholar
  105. 105.
    Ward NM, Brown VJ (1996) Covert orienting of attention in the rat and the role of striatal dopamine. J Neurosci 16: 3082–3088PubMedGoogle Scholar
  106. 106.
    Kitabatake Y, Hikida T, Watanabe D, Pastan I, Nakanishi S (2003) Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci USA 100: 7965–7970PubMedGoogle Scholar
  107. 107.
    Burmeister JJ, Palmer M, Gerhardt GA (2003) Ceramic-based multisite electrode array for rapid choline measures in brain tissue. Analytica Chimica Acta 481: 65–74Google Scholar
  108. 108.
    Lockman PR, Allen DD (2002) The transport of choline. Drug Dev Ind Pharm 28: 749–771PubMedGoogle Scholar
  109. 109.
    Acquas E, Di Chiara G (2001) Role of dopamine D1 receptors in the control of striatal acetylcholine release by endogenous dopamine. Neurol Sci 22: 41–42PubMedGoogle Scholar
  110. 110.
    Acquas E, Di Chiara G (1999) Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur J Pharmacol 383: 275–279PubMedGoogle Scholar
  111. 111.
    Johnson BJ, Bruno JP (1995) Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. Neuropharmacology 34: 191–203PubMedGoogle Scholar
  112. 112.
    DeBoer P, Heeringa MJ, Abercrombie ED (1996) Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur J Pharmacol 317: 257–262PubMedGoogle Scholar
  113. 113.
    Maurice N, Mercer J, Chan CS, Hernandez-Lopez S, Held J, Tkatch T, Surmeier DJ (2004) D2 dopamine receptor-mediated modulation of voltage-dependent Na+ channels reduces autonomous activity in striatal cholinergic interneurons. J Neurosci 24: 10289–10301PubMedGoogle Scholar
  114. 114.
    Bickerdike MJ, Abercrombie ED (1997) Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J Pharmacol Exp Ther 282: 818–826PubMedGoogle Scholar
  115. 115.
    Steinberg R, Souilhac J, Rodier D, Alonso R, Emonds-Alt X, Le Fur G, Soubrie P (1998) Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience 84: 511–518PubMedGoogle Scholar
  116. 116.
    Mandel RJ, Leanza G, Nilsson OG, Rosengren E (1994) Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Brain Res 653: 57–65PubMedGoogle Scholar
  117. 117.
    Sarter M, Bruno JP (1999) Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci 22: 67–74PubMedGoogle Scholar
  118. 118.
    Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV (2004) Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacol 174: 3–16Google Scholar
  119. 119.
    Stip E, Chouinard S, Boulay LJ (2005) On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiat 29: 219–232Google Scholar
  120. 120.
    Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96: 103–114PubMedGoogle Scholar
  121. 121.
    Robinson TE, Berridge KC (2003) Addiction. Ann Rev Psychol 54: 25–53Google Scholar
  122. 122.
    Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95Suppl 2: S91–117PubMedGoogle Scholar
  123. 123.
    Everitt BJ, Dickinson A, Robbins TW (2001) The neuropsychological basis of addictive behaviour. Brain Res Rev 36: 129–138PubMedGoogle Scholar
  124. 124.
    Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E et al. (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacol 20: 322–339Google Scholar
  125. 125.
    Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson III WE, Martin TJ (2004) Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 27: 841–850PubMedGoogle Scholar
  126. 126.
    Smith JE, Vaughn TC, Co C (2004) Acetylcholine turnover rates in rat brain regions during cocaine self-administration. J Neurochem 88: 502–512PubMedGoogle Scholar
  127. 127.
    Martinez V, Parikh V, Sarter M (2005) Sensitized attentional performance and Fosimmunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiat 57: 1138–1146.PubMedGoogle Scholar
  128. 128.
    Bednar I, Friberg L, Nordberg A (2004) Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats. Neurochem Int 45: 1049–1055PubMedGoogle Scholar
  129. 129.
    Cao YJ, Surowy CS, Puttfarcken PS (2005) Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release. Neuropharmacol 48: 72–79Google Scholar
  130. 130.
    Zhang L, Zhou FM, Dani JA (2004) Cholinergic drugs for Alzheimer’s disease enhance in vitro dopamine release. Mol Pharmacol 66: 538–544PubMedGoogle Scholar
  131. 131.
    Levin ED, M.W. D, Butcher LL (1992) Neurotransmitter interactions and cognitive function. In: Levin ED, Decker MW, Butcher LL (eds): Neurotransmitter interactions and cognitive function. Birkhäuser, Boston, 355–357Google Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2006

Authors and Affiliations

  • Martin Sarter
    • 1
  • John P. Bruno
    • 2
  • Vinay Parikh
    • 1
  • Vicente Martinez
    • 1
  • Rouba Kozak
    • 1
  • Jerry B. Richards
    • 3
  1. 1.Department of PsychologyUniversity of MichiganAnn ArborUSA
  2. 2.Departments of Psychology and NeuroscienceOhio State UniversityColumbusUSA
  3. 3.Research Institute on AddictionsBuffalo UniversityUSA

Personalised recommendations